BeiGene
BGNE
#935
Rank
C$29.60 B
Marketcap
$265.70
Share price
-2.08%
Change (1 day)
5.42%
Change (1 year)
BeiGene is a Chinese pharmaceutical company engaged in the R&D, and commercialization of molecularly-targeted, and immuno-oncology drugs for the treatment of cancer.

We have found no dividend yield history for this company